Schedule 13G ownership disclosure
DiaMedica Therapeutics Inc
Security class unavailable · CUSIP: 25253X207
Event date: 2019-10-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-19-008114
- Form type
- SC 13G
- Filer
- BIOLASE, INC
- CIK
- CIK 811240
- Filed
- Oct 31, 2019
- Reporting period
- Oct 25, 2019
- Description
- Schedule 13G beneficial ownership